Aerobic exercise moves nearly every metabolic dial in type 2 diabetes

Type 2 diabetes and obesity increasingly arrive together, a combination the authors call diabesity, and each condition compounds the health risks of the other. Aerobic exercise is routinely recommended for both, but its effects have more often been studied in diabetes or in obesity separately rather than in people living with the combined picture. This review set out to quantify what aerobic training actually changes across cardiometabolic health in adults with both conditions, measured against standard treatment alone, so that the advice rests on pooled trial evidence rather than assumption.

The authors searched multiple databases from inception to October 2024 for randomised controlled trials comparing aerobic exercise training lasting at least 2 weeks against standard treatment in adults with type 2 diabetes and concurrent overweight or obesity. Thirty-four trials met the criteria, together covering 1391 middle-aged and older adults, 55% of whom were women. The pooled outcomes spanned body composition measures such as body mass index, waist circumference and body fat, glucose control measures including fasting glucose and glycated haemoglobin, insulin and insulin resistance, and blood lipids.

Compared with standard treatment, aerobic exercise improved a long list of measures. Body mass index, waist circumference and body fat all fell, as did fasting blood glucose, glycated haemoglobin, fasting insulin and the standard index of insulin resistance. Blood lipids moved favourably too, with higher HDL cholesterol alongside lower triglycerides and total cholesterol. The standardised effects were mostly small to moderate in size, and the authors note considerable uncertainty in several of the outcomes, so the precise magnitudes should be read cautiously.

The direction of these findings is not surprising, since aerobic exercise is already a pillar of type 2 diabetes care, but pooling 34 trials in this specific combined population puts firmer evidence behind the advice. The breadth is the striking part: glucose control, insulin resistance, body composition and lipids all shifted together rather than one at a time. The review cannot say which types, intensities or durations of aerobic work matter most, and the acknowledged uncertainty in several outcomes leaves the exact effect sizes open.

For anyone carrying excess weight alongside type 2 diabetes, or supporting someone who is, this is a reason to see aerobic exercise as a broad-spectrum tool rather than simply a way to burn calories. The pooled trials suggest it nudges nearly every routine metabolic measure in a favourable direction compared with standard care alone. Because the effects were mostly modest, it reads as a complement to usual treatment rather than a replacement for it.